
|Articles|October 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Antimicrobial Use
- Volume 4
- Issue 11 Suppl
Selected Abstracts
Advertisement
Articles in this issue
about 27 years ago
Optimizing Antimicrobial Therapy and Emerging Pathogensabout 27 years ago
Participating Facultyabout 27 years ago
Introductionabout 27 years ago
Mechanisms and Current Rates of Resistanceabout 27 years ago
Influence of Antibiotics on the Normal Floraabout 27 years ago
Therapeutic Pathways for Antimicrobial Use: General Overviewabout 27 years ago
Therapeutic Pathways for Antimicrobial Use: Pediatric Issuesabout 27 years ago
Pharmacoeconomic Impact of Appropriate Clinical PathwaysNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
Rescue Therapy With Rozanolixizumab Promising in Triple-Seronegative MG
3
How Effective and Safe Are GLP-1s for Weight Loss?
4
FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome
5















































